Linglong Zou, PhD

Founder and CEO
Kanwhilsh Tech

A bioanalytical scientist and executive with 20+ years of experience in large-molecule PK, PD, immunogenicity, and biomarker assay development, validation, sample analysis, data interpretation, regulatory filing. lab operation and compliance. Im my carreer, I have supported 100+ biologic development, and among them 12 have been approved in US, EU, and/or China.

Poster(s):

• (T0930-09-54) A Generic Approach to Monkey Anti-drug Antibodies Assay Development for Antibody Therapeutic Preclinical Studies
  Tuesday, October 18, 2022

  9:30 AM – 10:30 AM ET

• (M1430-09-53) Development of a Generic Assay Platform Using Human IgG Light Chain-Specific Antibody Reagents for Concentration Measurement of Antibody Therapeutic in Preclinical Studies
  Monday, October 17, 2022

  2:30 PM – 3:30 PM ET

• (W0930-09-53) Preclinical Evaluation of Pharmacokinetic, Receptor Occupancy, and Immunogenicity Profiles of a Bispecific Antibody Construct in a Monkey Study
  Wednesday, October 19, 2022

  9:30 AM – 10:30 AM ET